HBS-301 tablet Clinical Trials (2026): 1 Studies for Idiopathic Hypersomnia
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 HBS-301 tablet clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Idiopathic Hypersomnia) and 248 total planned enrollment. 1 Phase 3 HBS-301 tablet trial are listed. 1 HBS-301 tablet clinical trial is actively recruiting at 12 U.S. sites across 8 states. Most recent activity: NCT07500090 (Oct 2028).
Where to Participate: All HBS-301 tablet Trial Sites in the U.S. (12 sites across 8 states)
Every actively recruiting HBS-301 tablettrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| CA | Santa Monica Clinical Trials | Santa Monica90404 | NCT07500090 | Map |
| FL | PharmDev Research Institute, LLC | Miami33176 | NCT07500090 | Map |
| FL | Central Florida Pediatric Sleep Disorders Institute (Florida Pediatric Research Institute, LLC) | Winter Park32789 | NCT07500090 | Map |
| GA | NeuroTrials Research Inc. | Atlanta30328 | NCT07500090 | Map |
| GA | Phillip Nowlin | Stockbridge30281 | NCT07500090 | Map |
| MO | St. Luke's Hospital, Sleep Medicine and Research Center | Chesterfield63017 | NCT07500090 | Map |
| NC | Clinical Research of Gastonia | Gastonia28054 | NCT07500090 | Map |
| NC | Stern Research Partners, LLC | Huntersville28078 | NCT07500090 | Map |
| NC | David Kudrow, MD | Morrisville27560 | NCT07500090 | Map |
| PA | Respiratory Specialists | Wyomissing19610 | NCT07500090 | Map |
| TN | K2 Medical Research | Nashville37204 | NCT07500090 | Map |
| WV | West Virginia University | Morgantown26506 | NCT07500090 | Map |
HBS-301 tablet clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P3 | 1 | 1 |
Recruiting HBS-301 tablet clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07500090 | IHA Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH) | P3 | Idiopathic Hypersomnia | 248 | Mar 2026 |
HBS-301 tablet pivotal trial highlights (Phase 2/3/4)
Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.
| Acronym | NCT | Phase | Status | Indication | Enrollment | PubMed |
|---|---|---|---|---|---|---|
| IH | NCT07500090 | P3 | recruiting | Idiopathic Hypersomnia | 248 | — |
All HBS-301 tablet trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07500090 | IH | A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH) | P3 | recruiting | 248 | Harmony Biosciences Management, Inc. | Mar 2026 |
HBS-301 tablet clinical trials: frequently asked questions
- How many HBS-301 tablet clinical trials are there?
- 1 HBS-301 tablet clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are HBS-301 tablet clinical trials recruiting in 2026?
- Yes — 1 HBS-301 tablet trial is actively recruiting in 2026, with 12 U.S. sites across 8 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is HBS-301 tablet being studied for?
- HBS-301 tablet is being studied for Idiopathic Hypersomnia. The trials are grouped by indication on this page.
- What phase is HBS-301 tablet in?
- HBS-301 tablet clinical trials span 1 Phase 3. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors HBS-301 tablet clinical trials?
- The lead sponsor across the most HBS-301 tablet trials is Harmony Biosciences Management, Inc.. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming HBS-301 tabletas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: